The epidemiology of epithelial ovarian cancer: A review

International Journal of Gynecological Cancer

Volumn 7, Issue 6, 1997, Pages 425-438

  Banks, Emily ^a   Beral, Valerie ^a   Reeves, Gillian ^a  

^a RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; ARTICLE; BREAST FEEDING; CANCER EPIDEMIOLOGY; CANCER RISK; DIET; FAMILY HISTORY; FEMALE; FEMALE STERILIZATION; HUMAN; HYSTERECTOMY; IONIZING RADIATION; MENARCHE; MENOPAUSE; OBESITY; ORAL CONTRACEPTION; OVARY CANCER; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOCIAL STATUS;

EID: 0031465360     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.1997.09756.x     Document Type: Article

References (134)

1. Parkin DM, Muir CS, Whelan SL, Gao Y-T, Ferlay J and Powell J, eds. Cancer Incidence in Five Continents. Lyon: IARC Scientific Publications, 1992; 770-773.
2. Jacobs IJ, Oram DA. Potential screening tests for ovarian cancer. In: Sharp F, Mason WP, Leake RE, eds. Ovarian Cancer. London: Chapman and Hall Medical, 1990; 197-205.
3. Whittemore AS, Harris R, Itnyre J, The Collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 1992; 136: 1184-1203.
4. Negri E, Franceschi S, Tzonou A, et al. Pooled analysis of 3 European case-control studies: I. Reproductive factors and risk of epithelial ovarian cancer, Int J Cancer 1991; 49: 50-56.
5. Purdie D, Green A, Bain C, et al. Reproductive and other factors and risk of epithelial ovarian cancer: An Australian case-control study, Int j Cancer 1995; 62: 678-684.
6. Risch HA, Marrett LD, Howe GR. Parity, contraception, infertility, and the risk of epithelial ovarian cancer. Am J Epidemiol 1994; 140: 585-597.
7. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Epithelial ovarian cancer and combined oral contraceptives, Int J Epidemiol 1989; 18: 538-545.
8. Booth M, Beral V. The epidemiology of ovarian cancer. In: Hudson CN, ed. Ovarian Cancer. Oxford: Oxford University Press, 1985; 22-44.
9. Fox H. Malignant potential of benign ovarian cysts: The case "against." In: Sharp F, Mason WP, Leake RE, eds. Ovarian Cancer. London: Chapman and Hall, 1990; 185-186.
10. Harlow BL, Weiss NS, Roth GJ, Chu J, Daling JR. Case-control study of borderline ovarian tumours: Reproductive history and exposure to exogenous female hormones. Cancer Res 1988; 48: 5849-5852.
11. Mant JWF, Vessey MP. Ovarian and Endometrial Cancers. In: Doll R, Fraumeni JF Jr, Muir CS, eds. Trends in Cancer Incidence and Mortality. Plainview: Cold Spring Harbor Laboratory Press, 1994: 287-307.
12. Weiss NS, Peterson AS. Racial variation in the incidence of ovarian cancer in the United States. Am J Epidemiol 1978; 107: 91-95.
13. Buell P, Dunn JE. Cancer mortality among Japanese Isseri and Niseri of California. Cancer 1965; 18: 656-664.
14. King H, Haenzel W. Cancer mortality among foreign and native-born Chinese in the United States. J Chron Dis 1973; 26: 623-646.
15. Kliewer EV, Smith KR. Ovarian cancer mortality among immigrants in Australia and Canada. Cancer Epidemiol Biomarkers Prev 1995; 4: 453-458.
16. Dos Santos Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer 1995; 72: 485-492.
17. Adami HO, Bergstrom R, Persson I, Sparen P. The incidence of ovarian cancer in Sweden, 1960-1984. Am J Epidemiol 1990; 132: 446-452.
18. Beral V, Fraser P, Chilvers C. Does pregnancy protect against ovarian cancer? Lancet 1978; 20: 1083-1087.
19. Ewertz M, Kjaer SK. Ovarian cancer incidence and mortality in Denmark 1943-1982. Int J Cancer 1988; 42: 690-696.
20. Beral V, Hannaford P, Kay C. Oral contraceptive use and malignancies of the genital tract. Results from the Royal College of General Practitioners' oral contraceptive study. Lancet 1988; ii: 1331-1334.
21. Booth M, Beral V, Smith P. Risk factors for ovarian cancer: A case control study. Br J Cancer 1989; 60: 592-598.
22. Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA. Risk factors for epithelial ovarian cancer in Beijing, China, Int J Epidemiol 1992; 21: 23-29.
23. Shu XO, Brinton LA, Gao YT, Yuan JM. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 1989; 49: 3670-3674.
24. Franceschi S, La Vecchia C, Helmrich SP, Mangioni C, Tognoni G. Risk factors for epithelial ovarian cancer in Italy. Am J Epidemiol 1982; 115: 714-719.
25. Hildreth NG, Kelsey JL, LiVolsi VA, et al. An epidemiologic study of epithelial carcinoma of the ovary. Am J Epidemiol 1981; 114: 398-405.
26. Koch M, Jenkins H, Gaedke H. Risk factors of ovarian cancer of epithelial origin: A case control study. Cancer Detect Prev 1988; 13: 131-136.
27. Mori M, Harabuchi I, Hirotsugu M, Casagrande JT, Henderson BE, Ross RK. Reproductive, genetic, and dietary risk factors for ovarian cancer. Am J Epidemiol 1988; 128: 771-777.
28. Newhouse ML, Pearson RM, Fullerton JM, Boesen EAM, Shannon HS. A case control study of carcinoma of the ovary. Br J Prev Soc Med 1977; 31: 148-153.
29. Tzonou A, Day NE, Trichopoulos D, et al. The epidemiology of ovarian cancer in Greece: A case-control study. Eur J Cancer Clin Oncol 1984; 20: 1045-1052.
30. Casagrande JT, Louie EW, Pike MC, Roy S, Ross RK, Henderson BE. "Incessant Ovulation" and ovarian cancer. Lancet 1979; ii: 170-172.
31. The Centers for Disease Control Cancer and Steroid Hormone Study. Oral contraceptive use and the risk of ovarian cancer. JAMA 1983; 249: 1596-1599.
32. Franceschi S, La Vecchia C, Mangioni C. Familial ovarian cancer: Eight more families. Gynecol Oncol 1982; 13: 31-36.
33. Fraumeni JF Jr, Grundy GW, Creagan ET, Everson RB. Six families prone to ovarian cancer. Cancer 1975; 36: 364-369.
34. Li FP, Rapport AH, Fraumeni JF, Jensen RD. Familial ovarian carcinoma. JAMA 1970; 214: 1559-1561.
35. Lurain JR, Piver MS. Familial ovarian cancer. Gynecol Oncol 1979; 8: 185-192.
36. Lynch HT, Harris RE, Guirgis HA, Maloney K, Carmody LL, Lynch JF. Familial association of breast/ovarian carcinoma. Cancer 1978; 41: 1543-1549.
37. Prior P, Waterhouse JAH. Multiple primary cancers of the breast and ovary. Br J Cancer 1981; 44: 628-636.
38. Amos CI, Struewing JP. Genetic epidemiology of epithelial ovarian cancer. Cancer 1993; 71: 566-572.
39. Friedman LS, Ostermeyer EA, Lynch ED, et al. The search for BRCA1. Cancer Res 1994; 54: 6374-6382.
40. Jacobs I, Lancaster J. The molecular genetics of sporadic and familial epithelial ovarian cancer, Int J Gynecol Cancer 1996; 6: 337-355.
41. Gayther SA, Mangion J, Russell P, et al. Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene. Nat Genet 1997; 15: 103-105.
42. Koch M, Gaedke H, Jenkins H. Family history of ovarian cancer patients: A case-control study, Int J Epidemiol 1989; 18: 782-785.
43. Bjorkholm E. Blood group distribution in women with ovarian cancer, Int J Epidemiol 1984; 13: 15-17.
44. Osbourne RH, De George FV. The ABO blood groups in neoplastic disease of the ovary. Am J Hum Genet 1963; 15: 380-388.
45. Franceschi S, La Vecchia C, Booth M, et al. Pooled analysis of 3 European case-control studies of ovarian cancer: II. Age at menarche and at menopause, Int J Cancer 1991; 49: 57-60.
46. Kvale G, Hench I, Nilssen S, Beral V. Reproductive factors and risk of ovarian cancer: A prospective study, Int J Cancer 1988; 42: 246-251.
47. McGowan L, Parent L, Lednar W, Norris HJ. The woman at risk for developing ovarian cancer. Gynecol Oncol 1979; 7: 325-344.
48. Willett WC, Bain C, Hennekens CH, Rosner B, Speizer FE. Oral contraceptives and risk of ovarian cancer. Cancer 1981; 48: 1684-1687.
49. Rodriguez C, Calle EE, Coates RJ, Miracle McMahill HL, Thun MJ, Heath CW, Jr. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol 1995; 141: 828-835.
50. Fraumeni JF Jr, Lloyd JW, Smith EM, Wagoner JK. Cancer mortality among nuns: Role of marital status in the etiology of neoplastic disease in women. J Natl Cancer Inst 1969; 42: 455-468.
51. Enstrom J. Cancer mortality among Mormons in California during 1968-1975. J Natl Cancer Inst 1980; 65: 1073-1082.
52. Phillips RL. Role of life-style and dietary habits in risk of cancer among Seventh-Day Adventists. Cancer Res 1975; 35: 3513-3522.
53. Adami HO, Hsieh CC, Lambe M, et al. Parity, age at first childbirth, and risk of ovarian cancer. Lancet 1994; 344: 1250-1254.
54. Annegers JF, Strom H, Decker DG, Dockerty MB, O'Fallon WM. Ovarian cancer: incidence and case-control study. Cancer 1979; 43: 723-729.
55. Hartge P, Schiffman MH, Hoover R, McGowan L, Lesher L, Norris HJ. A case-control study of epithelial ovarian cancer. Am J Obstet Gynecol 1989; 161: 10-16.
56. Nasca PC, Greenwald P, Chorost S, Richart R, Caputo T. An epidemiologic case-control study of ovarian cancer and reproductive factors. Am J Epidemiol 1984; 119: 705-713.
57. Wu ML, Whittemore AS, Paffenbarger RS, Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer. I. Reproductive and menstrual events and oral contraceptive use. Am J Epidemiol 1988; 128: 1216-1227.
58. Cramer DW, Welch WR, Cassells S, Scully RE. Mumps, menarche, menopause, and ovarian cancer. Am J Obstet Gynecol 1983; 147: 1-6.
59. Voigt LF, Harlow BL, Wiess NS. The influence of age at first birth and parity on ovarian cancer risk. Am J Epidemiol 1986; 124: 490-491.
60. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development. The reduction in risk of ovarian cancer associated with oral-contraceptive use. N Engl J Med 1987; 316: 650-655.
61. Cramer DW, Hutchison GB, Welch WR, Scully RE, Knapp RC. Factors affecting the association of oral contraceptives and ovarian cancer. N Engl J Med 1982; 307: 1047-1051.
62. Gross TP, Schlesselman JJ, Stadel BV, Yu W, Lee NC. The risk of epithelial ovarian cancer in short-term users of oral contraceptives. Am J Epidemiol 1992; 136: 46-53.
63. Parazzini F, La Vecchia C, Negri E, Bocciolone L, Fedele L, Franceschi S. Oral contraceptive use and the risk of ovarian cancer: An Italian case-control study. Eur J Cancer 1991; 27: 594-598.
64. Rosenberg L, Palmer JR, Zauber AG, et al. A case-control study of oral contraceptive use and invasive epithelial ovarian cancer. Am J Epidemiol 1994; 139: 654-661.
65. Vessey MP, Painter R. Endometrial and ovarian cancer and oral contraceptives - Findings in a large cohort study. Br J Cancer 1995; 71: 1340-1342.
66. Weiss NS, Lyon JL, Liff JM, Vollmer WM, Daling JR. Incidence of ovarian cancer in relation to the use of oral contraceptives. Int J Cancer 1981; 28: 669-671.
67. Franceschi S, Parazzini F, Negri E, et al. Pooled analysis of 3 European case-control studies of epithelial ovarian cancer: III. Oral contraceptive use. Int J Cancer 1991; 49: 61-65.
68. Hartge P, Hoover R, McGowan L, Lesher L, Norris HJ. Menopause and ovarian cancer. Am J Epidemiol 1988; 127: 990-998.
69. Cramer DW, Hutchison GB, Welch WR, Scully RE, Ryan KJ. Determinants of ovarian cancer risk. I. Reproductive experiences and family history. J Natl Cancer Inst 1983; 71: 711-716.
70. Kaufman DW, Kelly JP, Welch WR, et al. Noncontraceptive estrogen use and epithelial ovarian cancer. Am J Epidemiol 1989; 130: 1142-1151.
71. Polychronopoulou A, Tzonou A, Hsieh CC, et al. Reproductive variables, tobacco, ethanol, coffee and somatometry as risk factors for ovarian cancer. Int J Cancer 1993; 55: 402-407.
72. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980s in two south-eastern New England communities. Am J Epidemiol 1993; 137: 1125-1135.
73. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990; 163: 1438-1444.
74. Hoover R, Gray LA, Fraumeni JF. Stilboestrol (Diethyl-stilbestrol) and the risk of ovarian cancer. Lancet 1977; ii: 533-534.
75. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives. Depotmedroxyprogesterone acetate (DMPA) and risk of epithelial ovarian cancer, Int J Cancer 1991; 49: 191-195.
76. Weiss NS, Lyon JL, Krishnamurthy S, Dietert SE, Liff JM, Daling JR. Noncontraceptive estrogen use and the occurrence of ovarian cancer. J Natl Cancer Inst 1982; 68: 95-98.
77. Liang AP, Levenson AG, Layde PM, et al. Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. JAMA 1983; 249: 2909-2912.
78. Joly DJ, Lilienfeld AM Diamond EL, Bross IDJ. An epidemiologic study of the relationship of reproductive experience to cancer of the ovary. Am J Epidemiol 1974; 99: 190-209.
79. Franceschi S, La Vecchia C, Negri E, et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 1994; 9: 1673-1675.
80. Brinton LA, Melton LJ, Malkasian GDJ, Bond A, Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 1989; 129: 712-722.
81. Ron E, Lunenfeld B, Menczer J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987; 125: 780-790.
82. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Ovarian tumors in a cohort of infertile women. N Engl J Med 1994; 331: 771-776.
83. Venn A, Watson L, Lumley J, Giles G, King C, Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet 1995; 346: 995-1000.
84. Dietl J. Ovulation and ovarian cancer. Lancet 1991; 338: 445.
85. Fishel S, Jackson P. Follicular stimulation for high tech pregnancies: Are we playing it safe? Br Med J 1989; 299: 309-311.
86. Kulkarni R, McGarry JM. Follicular stimulation and ovarian cancer. Br Med J 1989; 299: 740.
87. Shushan A, Paltiel O, Iscovich J, Elchalal U, Peretz T, Schenker JG. Human menopausal gonadotropin and the risk of epithelial ovarian cancer. Fertil Steril 1996; 65: 13-18.
88. Hankinson SE, Hunter DJ, Colditz GA, et al. Tubal Iigation, hysterectomy, and risk of ovarian cancer. JAMA 1993; 270: 2813-2818.
89. Irwin KL, Weiss NS, Lee NC, Peterson HB. Tubal sterilization, hysterectomy and the subsequent occurrence of epithelial ovarian cancer. Am J Epidemiol 1991; 134: 362-369.
90. Parazzini F, Negri E, La Vecchia C, Luchini L, Mezzopane R. Hysterectomy, oophorectomy, and subsequent ovarian cancer risk. Obstet Gynecol 1993; 81: 363-366.
91. Weiss NS, Harlow BL. Why does hysterectomy without bilateral oophorectomy influence the subsequent incidence of ovarian cancer? Am J Epidemiol 1986; 124: 856-858.
92. Nandakumar A, Anantha N, Dhar M, et al. A case-control investigation on cancer of the ovary in Bangalore, India. Int J Cancer 1995; 63: 361-365.
93. Cramer DW, Welch WR, Scully RE, Wojciechowski CA. Ovarian cancer and talc: A case-control study. Cancer 1982; 50: 372-376.
94. Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer 1974; 15: 617-631.
95. La Vecchia C, Decarli A, Negri E, et al. Dietary factors and the risk of epithelial ovarian cancer. J Natl Cancer Inst 1987; 79: 663-669.
96. Risch HA, Jain M, Marrett LD, Howe GR. Dietary fat intake and risk of epithelial ovarian cancer. J Natl Cancer Inst 1994; 86: 1409-1415.
97. Shu XO, Gao YT, Yuan JM, Ziegler RG, Brinton LA. Dietary factors and epithelial ovarian cancer. Br J Cancer 1989; 59: 92-96.
98. Tzonou A, Hsieh CC, Polychronopoulou A, et al. Diet and ovarian cancer: A case-control study in Greece. Int J Cancer 1993; 55: 411-414.
99. Cramer DW, Harlow BL, Willett WC, et al. Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet 1989; 2: 66-71.
100. Harlow BL, Cramer DW, Geller J, Willett WC, Bell DA, Welch WR. The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol 1991; 134: 445-453.
101. Engle A, Muscat JE, Harris RE. Nutritional risk factors and ovarian cancer. Nutr Cancer 1991; 15: 239-247.
102. Herrinton LJ, Weiss NS, Beresford SA, et al. Lactose and galactose intake and metabolism in relation to the risk of epithelial ovarian cancer. Am J Epidemiol 1995; 141: 407-416.
103. Mettlin CJ, Piver MS. A case-control study of milk-8drinking and ovarian cancer risk. Am J Epidemiol 1990; 132: 871-876.
104. Risch HA, Jain M, Marrett LD, Howe GR. Dietary lactose intake, lactose intolerance, and the risk of epithelial ovarian cancer in southern Ontario (Canada). Cancer Causes Control 1994; 5: 540-548.
105. Byers T, Marshall J, Graham S, Mettlin C, Swanson M. A case-control study of dietary and nondietary factors in ovarian cancer. J Natl Cancer Inst 1983; 71: 681-686.
106. Gwinn ML, Webster LA, Lee NC, Layde PM, Rubin GL. Alcohol consumption and ovarian cancer risk. Am J Epidemiol 1986; 123: 759-766.
107. La Vecchia C, Negri E, Franceschi S, Parazzini F, Gentile A, Fasoli M. Alcohol and epithelial ovarian cancer. J Clin Epidemiol 1992; 45: 1025-1030.
108. Whittemore AS, Wu ML, Paffenbarger RS Jr, et al. Personal and environmental characteristics related to epithelial ovarian cancer. II. Exposures to talcum powder, tobacco, alcohol, and coffee. Am J Epidemiol 1988; 128: 1228-1240.
109. Doll R, Gray R, Hafner B, Peto R. Mortality in relation to smoking: 22 years' observations on female British doctors. Br Med J 1980; 280: 967-971.
110. Franks AL, Lee NC, Kendrick JS, Rubin GL, Layde PM. Cigarette smoking and the risk of epithelial ovarian cancer. Am J Epidemiol 1987; 126: 112-117.
111. Smith EM, Sowers MF, Burns TL. Effects of smoking on the development of female reproductive cancers. J Natl Cancer Inst 1984; 73: 371-376.
112. Venter PF. Ovarian epithelial cancer and chemical carcinogenesis. Gynecol Oncol 1981; 12: 281-285.
113. Henderson WJ, Joslin CAF, Turnbull AC, Griffiths K. Talc and carcinoma of the ovary and cervix. J Obstet Gynaecol Br Comm 1971; 78: 266-272.
114. Harlow BL, Cramer DW, Bell DA, Welch WR. Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol 1992; 80: 19-26.
115. Cook LS, Kamb ML, Weiss NS. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 1997; 145: 459-465.
116. Hartge P, Hoover R, Lesher LP, McGowan L. Talc and ovarian cancer (letter). JAMA 1983; 250: 1844.
117. Tzonou A, Polychronopoulou A, Hsieh CC, Rebelakos A, Karakatsani A, Trichopoulos D. Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer, Int J Cancer 1993; 55: 408-410.
118. Wehner AP. Biological effects of cosmetic talc. Food Chem Toxicol 1994; 32: 1173-1184.
119. Longo DL, Young RC. Cosmetic talc and ovarian cancer (letter). Lancet 1979; 2: 1011-1012.
120. Newhouse ML. Cosmetic talc and ovarian cancer (letter). Lancet 1979; 2: 528.
121. Menczer J, Modan M, Ranon L, Golan A. Possible role of mumps virus in the etiology of ovarian cancer. Cancer 1979; 43: 1375-1379.
122. West RO. Epidemiologic study of malignancies of the ovaries. Cancer 1966; 19: 1001-1007.
123. Golan A, Joosting AC, Orchard ME. Mumps virus and ovarian cancer. S Afr Med J 1979; 56: 18-20.
124. Brinkley D, Haybrittle JL. The late effects of artificial menopause by X-radiation. Br J Radiol 1969; 42: 519-521.
125. Smith PG, Doll R. Late effects of X irradiation in patients treated for metropathia haemorrhagica. Br J Radiol 1976; 49: 224-232.
126. Darby SC, Reeves G, Key T, Doll R, Stovall M. Mortality in a cohort of women given X-ray therapy for metropathia haemorrhagica. Int J Cancer 1994; 56: 793-801.
127. Fathalla MF. Incessant ovulation - A factor in ovarian neoplasia? Lancet 1971; 2: 163.
128. Gwinn ML, Lee NC, Rhodes PH, Layde PM, Rubin GL. Pregnancy, breast feeding, and oral contraceptives and the risk of epithelial ovarian cancer. J Clin Epidemiol 1990; 43: 559-568.
129. Lund E. Mortality from ovarian cancer among women with many children, Int J Epidemiol 1992; 21: 872-876.
130. Risch HA, Weiss NS, Lyon JL, Daling JR, Liff JM. Events of reproductive life and the incidence of epithelial ovarian cancer. Am J Epidemiol 1983; 117: 128-139.
131. Cramer DW, Welch WR. Determinants of ovarian cancer risk. II. Inferences regarding pathogenesis. J Natl Cancer Inst 1983; 71: 717-721.
132. Mohle J, Whittemore A, Pike M, Darby S. Gonadotrophins and ovarian cancer risk. J Natl Cancer Inst 1985; 75: 178-179.
133. Helzlsouer KJ, Alberg AJ, Gordon GB, et al. Serum gonadotropins and steroid hormones and the development of ovarian cancer. JAMA 1995; 274: 1926-1930.
134. Whittemore AS, Harris R, Itnyre J. Characteristics relating to ovarian cancer risk: Collaborative analysis of 12 US case-control studies. IV. The pathogenesis of epithelial ovarian cancer. Collaborative Ovarian Cancer Group. Am J Epidemiol 1992; 136: 1212-1220.